These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3395669)

  • 1. Changes in salicylate serum concentration and metabolism during chronic dosing in normal volunteers.
    Day RO; Furst DE; Dromgoole SH; Paulus HE
    Biopharm Drug Dispos; 1988; 9(3):273-83. PubMed ID: 3395669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salicylate pharmacokinetics in patients with rheumatoid arthritis.
    Owen SG; Roberts MS; Friesen WT; Francis HW
    Br J Clin Pharmacol; 1989 Oct; 28(4):449-61. PubMed ID: 2590603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.
    Shen J; Wanwimolruk S; Purves RD; McQueen EG; Roberts MS
    J Pharmacokinet Biopharm; 1991 Oct; 19(5):575-95. PubMed ID: 1783992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis.
    Bochner F; Graham GG; Polverino A; Imhoff DM; Tregenza RA; Rolan PE; Cleland LG
    Eur J Clin Pharmacol; 1987; 32(2):153-8. PubMed ID: 3582479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of salicyluric acid formation in rheumatoid arthritis patients treated with salicylates.
    Day RO; Shen DD; Azarnoff DL
    Clin Pharmacokinet; 1983; 8(3):263-71. PubMed ID: 6851371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of the salicylates.
    Needs CJ; Brooks PM
    Clin Pharmacokinet; 1985; 10(2):164-77. PubMed ID: 3888490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of five metabolites of aspirin by UHPLC-MS/MS coupled with enzymatic reaction and its application to evaluate the effects of aspirin dosage on the metabolic profile.
    Li JP; Guo JM; Shang EX; Zhu ZH; Liu Y; Zhao BC; Zhao J; Tang ZS; Duan JA
    J Pharm Biomed Anal; 2017 May; 138():109-117. PubMed ID: 28192718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous absorption of salicylic acid after repeated (14-day) in vivo administration to normal, acnegenic or aged human skin.
    Davis DA; Kraus AL; Thompson GA; Olerich M; Odio MR
    J Pharm Sci; 1997 Aug; 86(8):896-9. PubMed ID: 9269866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of salicylic acid following topically applied salicylate derivatives.
    Morra P; Bartle WR; Walker SE; Lee SN; Bowles SK; Reeves RA
    Ann Pharmacother; 1996 Sep; 30(9):935-40. PubMed ID: 8876850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct analysis of salicylic acid, salicyl acyl glucuronide, salicyluric acid and gentisic acid in human plasma and urine by high-performance liquid chromatography.
    Liu JH; Smith PC
    J Chromatogr B Biomed Appl; 1996 Jan; 675(1):61-70. PubMed ID: 8634769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and elimination of salicylic acid in rabbits.
    Short CR; Neff-Davis CA; Hsieh LC; Koritz GD; Malbrough MS; Barker SA; Davis LE
    J Vet Pharmacol Ther; 1991 Mar; 14(1):70-7. PubMed ID: 2038097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of aspirin after therapeutic and toxic doses.
    Patel DK; Hesse A; Ogunbona A; Notarianni LJ; Bennett PN
    Hum Exp Toxicol; 1990 May; 9(3):131-6. PubMed ID: 2375880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma acetylsalicylic acid and salicylic acid levels during aspirin provocation in aspirin-sensitive subjects.
    Dahlén B; Boréus LO; Anderson P; Andersson R; Zetterström O
    Allergy; 1994 Jan; 49(1):43-9. PubMed ID: 8198239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of salicyluric and salicylic acids by non-vegetarians, vegetarians, and patients taking low dose aspirin.
    Lawrence JR; Peter R; Baxter GJ; Robson J; Graham AB; Paterson JR
    J Clin Pathol; 2003 Sep; 56(9):651-3. PubMed ID: 12944546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salicylate metabolism: effects of age and sex in adults.
    Montgomery PR; Berger LG; Mitenko PA; Sitar DS
    Clin Pharmacol Ther; 1986 May; 39(5):571-6. PubMed ID: 3698465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct gradient reversed-phase high-performance liquid chromatographic determination of salicylic acid, with the corresponding glycine and glucuronide conjugates in human plasma and urine.
    Vree TB; van Ewijk-Beneken Kolmer EW; Verwey-van Wissen CP; Hekster YA
    J Chromatogr; 1994 Feb; 652(2):161-70. PubMed ID: 8006100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of salicylates: a re-assessment.
    Levy G
    Br J Clin Pharmacol; 1980 Oct; 10 Suppl 2(Suppl 2):285S-290S. PubMed ID: 7437270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct measurement of salicylphenolic glucuronide in human urine.
    Imhoff DM; Reece PA; Dimitriadis E; Ward AD; Bochner F
    Ther Drug Monit; 1986; 8(3):321-5. PubMed ID: 3750376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative determination of the main metabolites of acetylsalicylic acid. 1. A method for the quantitative determination of salicylic acid and its metabolites. Studies in healthy individuals].
    Pütter J
    Arzneimittelforschung; 1975 Jun; 25(6):941-4. PubMed ID: 1174333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers.
    Benedek IH; Joshi AS; Pieniaszek HJ; King SY; Kornhauser DM
    J Clin Pharmacol; 1995 Dec; 35(12):1181-6. PubMed ID: 8750369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.